PhytoSquene - The world's first plant-based squalene in the world in GMP quality

PhytoSquene® is our non-animal-derived squalene that can be used in vaccines and other pharmaceutical applications. This alternative to animal-derived squalene has many benefits. PhytoSquene® reduces the need to source pharma-grade squalene from sharks, therefore helping to preserve biodiversity and ecosystems. It is non-immunogenic and has a high and consistent quality. No CMR (carcinogenic, mutagenic or toxic) processes are involved in manufacturing. PhytoSquene® is compliant with European Pharmacopoeia regulations (Ph. Eur. monograph 2805). Squalene is found in shark livers, higher fungi, yeast, microbes and many plant sources. Up until now, shark liver oil, for example, from the spiny dogfish (Squalus acanthias) has been the only source of pharma-grade squalene. It takes between 2,500 and 3,000 sharks to extract roughly a ton of the product. PhytoSquene® is our non-animal-derived alternative that is based on amaranth oil. Amaranth (Amaranthus caudatus) is a herbaceous plant that is cultivated in many regions of the world as a crop. It can be grown in colder regions including Argentina, Bolivia and Peru. Amaranth oil is extracted from the amaranth seed via supercritical CO2 reduction. To extract the squalene the amaranth oil is enriched via a membrane the crude squalene produced is then purified via chromatography and isolated via distillation before drying and packing.